D. Gauvreau

发表

Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses.

Sébastien Gagné, Eric Langlois, Jean-François Truchon, 2014, Bioorganic & medicinal chemistry letters.

Convergent Kilo-Scale Synthesis of a Potent Renin Inhibitor for the Treatment of Hypertension

E. Corley, Louis-Charles Campeau, D. Gauvreau, 2011 .

Deficiency of C5L2 Increases Macrophage Infiltration and Alters Adipose Tissue Function in Mice

K. Cianflone, D. Gauvreau, A. Gupta, 2013, PloS one.

Convergent, Fit-For-Purpose, Kilogram-Scale Synthesis of a 5-Lipoxygenase Inhibitor

I. Davies, G. Hughes, Louis-Charles Campeau, 2012 .

Novel oxazolidinone calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraine.

H. Selnick, M. Fraley, D. Gauvreau, 2015, Bioorganic & medicinal chemistry letters.

Expression of prostaglandin E synthases in the bovine oviduct.

D. Gauvreau, J. Bilodeau, M. Fortier, 2010, Theriogenology.

Practical synthesis of a potent bradykinin B(1) antagonist via enantioselective hydrogenation of a pyridyl N-acyl enamide.

F. Gosselin, G. Hughes, D. Gauvreau, 2009, The Journal of organic chemistry.

A practical enantioselective synthesis of odanacatib, a potent Cathepsin K inhibitor, via triflate displacement of an alpha-trifluoromethylbenzyl triflate.

F. Gosselin, G. Hughes, R. Volante, 2009, The Journal of organic chemistry.

A practical synthesis of 5-lipoxygenase inhibitor MK-0633.

I. Davies, F. Gosselin, M. Palucki, 2010, The Journal of organic chemistry.

Oxidation of aromatic and aliphatic triisopropylsilanylsulfanyls to sulfonyl chlorides: preparation of sulfonamides

Y. Gareau, D. Gauvreau, Sébastien Laliberté, 2003 .

A Robust Kilo-Scale Synthesis of Doravirine

Wei Zhang, Qinghao Chen, Kevin M. Belyk, 2016 .

Practical synthesis of a renin inhibitor via a diastereoselective Dieckmann cyclization.

Bing Yu, I. Davies, G. Hughes, 2010, Organic letters.

Scalable synthesis of a prostaglandin EP4 receptor antagonist.

I. Davies, G. Hughes, D. Gauvreau, 2010, The Journal of organic chemistry.

Convergent Approach to Nonsymmetrical2,5-Diester Pyrroles

Louis-Charles Campeau, D. Gauvreau, Éric Lévesque, 2010 .

Preparation and reactivity studies of 1,2-bis-triisopropylsilanylsulfanyl-alkenes

Y. Gareau, M. Tremblay, D. Gauvreau, 2001 .

Convergent Kilogram-Scale Synthesis of Dual Orexin Receptor Antagonist

Paul N. Devine, Louis-Charles Campeau, Paul D. O’Shea, 2013 .

CRTH2 antagonist MK-7246: a synthetic evolution from discovery through development.

Stephen Lau, Danny Gauvreau, D. Gauvreau, 2012, The Journal of organic chemistry.

Hormonal and spatial regulation of nitric oxide synthases (NOS) (neuronal NOS, inducible NOS, and endothelial NOS) in the oviducts.

S. Kimmins, J. Lapointe, D. Gauvreau, 2006, Endocrinology.

Nucleophilic displacements of non-racemic α-trifluoromethyl benzylic triflates

G. Hughes, D. Gauvreau, P. O'shea, 2009 .

[Novel adipokines: links between obesity and atherosclerosis].

K. Cianflone, Y. Deshaies, N. Villeneuve, 2011, Annales d'endocrinologie.

A new effector of lipid metabolism: complement factor properdin.

K. Cianflone, D. Richard, D. Gauvreau, 2012, Molecular immunology.

Recombinant Acylation Stimulating Protein Administration to C3−/− Mice Increases Insulin Resistance via Adipocyte Inflammatory Mechanisms

K. Cianflone, D. Richard, M. Munkonda, 2012, PloS one.

Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation.

K. Cianflone, D. Gauvreau, M. Lapointe, 2009, Molecular immunology.

Differential chemoattractant response in adipocytes and macrophages to the action of acylation stimulating protein.

K. Cianflone, D. Gauvreau, M. Lapointe, 2013, European journal of cell biology.

C5L2 and C5aR interaction in adipocytes and macrophages: insights into adipoimmunology.

K. Cianflone, D. Devost, T. Hébert, 2013, Cellular signalling.

Expression of superoxide dismutases in the bovine oviduct during the estrous cycle.

D. Gauvreau, J. Bilodeau, M. Roy, 2008, Theriogenology.

Acute injection of ASP in the third ventricle inhibits food intake and locomotor activity in rats.

E. Timofeeva, K. Cianflone, D. Richard, 2011, American journal of physiology. Endocrinology and metabolism.

Evaluation of chylomicron effect on ASP production in 3T3-L1 adipocytes.

K. Cianflone, S. Paglialunga, D. Gauvreau, 2011, Acta biochimica et biophysica Sinica.

Inflammatory markers and adipokines alter adipocyte-derived ASP production through direct and indirect immune interaction.

K. Cianflone, D. Gauvreau, M. Lapointe, 2013, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Remote electronic control in the regioselective reduction of succinimides: a practical, scalable synthesis of Ep4 antagonist MF-310.

Yongxin Han, C. Raab, M. Palucki, 2009, The Journal of organic chemistry.

Hormone and pharmaceutical regulation of ASP production in 3T3‐L1 adipocytes

K. Cianflone, D. Gauvreau, Ying Gao, 2010, Journal of cellular biochemistry.

A new effector of lipid metabolism: complement factor properdin.

K. Cianflone, D. Richard, D. Gauvreau, 2012, Molecular immunology.

Conservation of the planar chiral information in the tandem oxy-cope/ene reaction.

D. Gauvreau, L. Barriault, 2005, The Journal of organic chemistry.